Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Di Pierro$n$ et al., Frontiers in Pharmacology, doi:10.3389/fphar.2022.1096853
https://c19early.org/dipierro5.html